BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.61
-0.07 (-0.91%)
At close: Nov 13, 2026, 4:00 PM EST
7.61
0.00 (-0.01%)
After-hours: Nov 13, 2026, 7:55 PM EST
BioCryst Pharmaceuticals Employees
BioCryst Pharmaceuticals had 435 employees as of December 31, 2025. The number of employees decreased by 145 or 25.00% compared to the previous year. That makes BioCryst Pharmaceuticals the 21,151st largest employer in the world and 2,778th in the United States.
Employees
435
Change (1Y)
-145
Growth (1Y)
-25.00%
Revenue / Employee
$2,210,368
Profits / Employee
-$826,795
Market Cap
1.96B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 435 | -145 | -25.00% |
| Dec 31, 2024 | 580 | 44 | 8.21% |
| Dec 31, 2023 | 536 | 5 | 0.94% |
| Dec 31, 2022 | 531 | 173 | 48.32% |
| Dec 31, 2021 | 358 | 112 | 45.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| Phibro Animal Health | 2,605 |
| HUTCHMED (China) | 1,790 |
| Alvotech | 1,279 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
| Pacira BioSciences | 829 |
BCRX News
- 1 day ago - BioCryst presents evidence on use of once-daily Orladeyo - TheFly
- 1 day ago - BioCryst Presents New Real-World Evidence Showing Reduced Angioedema-Related Medical Visits After Switching to ORLADEYO® (berotralstat) at ACAAI 2026 Annual Scientific Meeting - GlobeNewsWire
- 10 days ago - BioCryst to Present at Upcoming Investor Conferences - GlobeNewsWire
- 10 days ago - BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 10 days ago - BioCryst Pharmaceuticals Earnings release: Q3 2026 - Filings
- 10 days ago - BioCryst Pharmaceuticals Slides: Q3 2026 - Filings
- 10 days ago - BioCryst Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 10 days ago - BioCryst Reports Third Quarter 2026 Financial Results - GlobeNewsWire